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ANDV       Andes hantavirus 
CARDs       caspase-recruitment domains 
CHX      cycloheximide 
cRNA       antigenomic RNA 
DOBV      Dobrava hantavirus 
dsRNA       double-stranded RNA 
ECM       extracellular matrix  
eIF4F       eukaryotic translation initiation factor 4F 
FACS      flow cytometry 
GFP      green fluorescent protein 
Gn-CT       Gn glycoprotein cytoplasmic tail  
GPC       glycoprotein precursor 
GST       glutathione-S-transferase 
HCPS      hantavirus cardiopulmonary syndrome 
HFRS      hemorrhagic fever with renal syndrome 
HLA       human leukocyte antigen 
HTNV       Hantaan hantavirus 
IFN       interferon 
IKK      IB kinase-
IPS-I       IFN- promoter stimulator  
IPTG      isopropyl--D-1-thiogalactopyranoside 
IRESs              cis-acting internal ribosomal entry site 
IRF                     interferon regulatory factor 
ITAM      immunoreceptor tyrosine based activation motif 
MDA5       melanoma differentiation-associated gene 5 
MHC       major histocompatibility complex 
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MTOC      microtubule organizing center 
MyD88      myeloid differentiation primary response gene (88) 
NCR       non-coding region 
NE       nephropahia epidemica 
NF-B  nuclear factor -light-chain-enhancer of activated B 
cells 
NOC  nocodazole 
NY-1       New York-1 hantavirus 
ORF      open reading frame 
PAMPs      pathogen-associated molecular patterns 
PHV       Prospect Hill hantavirus 
PRRs       pattern recognition receptors  
PUUV  Puumala virus 
RdRp       RNA-dependent RNA polymerase 
RIG-I      retinoic acid inducible gene I 
RLH       retinoic acid-inducible gene I-like RNA helicases 
SAAV       Saaremaa hantavirus 
SEOV       Seoul hantavirus 
SFV       Semliki Forest virus 
SNV       Sin Nombre hantavirus 
TBK-1       TANK-binding kinase 1 
TLR       Toll-like receptor 
TNF-        tumor necrosis factor alpha 
TRAF3      TNF receptor-associated factor 3 
TULV  Tula hantavirus 
vRNA       viral RNA 







Hantaviruses have a tri-segmented negative-stranded RNA genome. The S segment 
encodes the nucleocapsid protein (N), M segment two glycoproteins, Gn and Gc, and the L 
segment the RNA polymerase. Gn and Gc are co-translationally cleaved from a precursor and 
targeted to the cis-Golgi compartment. The Gn glycoprotein consists of an external domain, a 
transmembrane domain and a C-terminal cytoplasmic domain. In addition, the S segment of 
some hantaviruses, including Tula and Puumala virus, have an open reading frame (ORF) 
encoding a nonstructural potein NSs that can function as a weak interferon antagonist. 
The mechanisms of hantavirus-induced pathogenesis are not fully understood but it is 
known that both hemorrhagic fever with renal syndrome (HFRS) and hantavirus (cardio) 
pulmonary syndrome (HCPS) share various features such as increased capillary permeability, 
thrombocytopenia and upregulation of TNF-. Several hantaviruses have been reported to 
induce programmed cell death (apoptosis), such as TULV-infected Vero E6 cells which is  
known to be defective in interferon signaling. Recently reports describing properties of the 
hantavirus Gn cytoplasmic tail (Gn-CT) have appeared. The Gn-CT of hantaviruses contains 
animmunoreceptor tyrosine-based activation motif (ITAM) which directs receptor signaling 
in immune and endothelial cells; and contain highly conserved classical zinc finger domains 
which may have a role in the interaction with N protein. More functions of Gn protein have 
been discovered, but much still remains unknown.  
Our aim was to study the functions of Gn protein from several aspects: synthesis, 
degradation and interaction with N protein. Gn protein was reported to inhibit interferon 
induction and amplication. For this reason, we also carried out projects studying the 
mechanisms of IFN induction and evasion by hantavirus.  
We first showed degradation and aggresome formation of the Gn-CT of the apathogenic 
TULV. It was reported earlier that the degradation of Gn-CT is related to the pathogenicity of 
hantavirus. We found that the Gn-CT of the apathogenic hantaviruses (TULV, Prospect Hill 
virus) was degraded through the ubiquitin-proteasome pathway, and TULV Gn-CT formed 
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aggresomes upon treatment with proteasomal inhibitor. Thus the results suggest that 
degradation and aggregation of the Gn-CT may be a general property of most hantaviruses, 
unrelated to pathogenicity. 
Second, we investigated the interaction of TULV N protein and the TULV Gn-CT. The 
Gn protein is located on the Golgi membrane and its interaction with N protein has been 
thought to determine the cargo of the hantaviral ribonucleoprotein which is an important step 
in virus assembly, but direct evidence has not been reported. We found that TULV Gn-CT 
fused with GST tag expressed in bacteria can pull-down the N protein expressed in 
mammalian cells; a mutagenesis assay was carried out, in which we found that the zinc finger 
motif in Gn-CT and RNA-binding motif in N protein are indispensable for the interaction.  
For the study of mechanisms of IFN induction and evasion by Old World hantavirus, we 
found that Old World hantaviruses do not produce detectable amounts of dsRNA in infected 
cells and the 5’-termini of their genomic RNAs are monophosphorylated. DsRNA and 
tri-phosphorylated RNA are considered to be critical activators of innate immnity response 
by interacting with PRRs (pattern recognition receptors). We examined systematically the 
5 -´termini of hantavirus genomic RNAs and the dsRNA production by different species of 
hantaviruses. We found that no detectable dsRNA was produced in cells infected by the two 
groups of the old world hantaviruses: Seoul, Dobrava, Saaremaa, Puumala and Tula. We 
also found that the genomic RNAs of these Old World hantaviruses carry 
5 -´monophosphate and are unable to trigger interferon induction.   
The antiviral response is mainly mediated by alpha/beta interferon. Recently the 
glycoproteins of the pathogenic hantaviruses Sin Nombre and New York-1 viruses were 
reported to regulate cellular interferon. We found that Gn-CT can inhibit the induction of 
IFN activation through Toll-like receptor (TLR) and retinoic acid-inducible gene I-like 
RNA helicases (RLH) pathway and that the inhibition target lies at the level of 
TANK-binding kinase 1 (TBK-1)/ IB kinase-IKK complex and myeloid 





4 Review of the literature 
4.1 Overview of hantaviruses 
Hantaviruses are RNA viruses within the family Bunyaviridae (Nichol, 2005). 
They are found worldwide and are associated with two severe disease syndromes: 
hemorrhagic fever with renal syndrome (HFRS) and hantavirus (cardio) pulmonary 
syndrome (HCPS) (Heyman et al., 2009; Vapalahti et al., 2003). 
Unlike the rest of the family Bunyaviridae, which are arthropod-borne, the 
carriers of hantaviruses are rodents and insectivores (Heyman et al., 2009; Vaheri et 
al., 2011). These viruses are transmitted directly or indirectly between hosts through 
aggressive interactions or the inhalation of infectious aerosols released in saliva, urine 
and feces (Plyusnin and Morzunov, 2001). In insectivores, recently, new hantaviruses 
have been detected in shrews (Klempa et al., 2007; Song et al., 2007). In rodents, 
hantaviruses are found in the Cricetidae family (subfamilies Arvicolinae, Neotominae 
and Sigmodontinae) and in the Muridae family (subfamily Murinae). Each hantavirus 
type is carried primarily by a specific rodent host species and they are co-evolving 
with their hosts (Khaiboullina et al., 2005; Plyusnin et al., 1996).  
In Europe, HFRS is caused by three hantaviruses: Puumala virus (PUUV) 
(Brummer-Korvenkontio et al., 1982), Dobrava virus (DOBV) (Avsic-Zupanc et al., 
1992) and Saaremaa virus (SAAV) (Plyusnin et al., 1997). In Finland, a total of    
22, 681 cases of PUUV-caused mild HFRS were reported from 1995 to 2008 (average 
annual incidence 31/100 000 population). There has been an increasing trend in 
incidence, and the rates have varied widely by season and region (Makary et al., 2010; 





Before the identification of the causative agent of HFRS in 1976 by Dr. Ho Wang 
Lee (Lee et al., 1978), the human diseases of HFRS type had already been described 
long time ago. In A.D. 960, a Chinese medical account described a similar disease 
(Lee et al., 1982). In 1934, Japanese physicians first encountered HFRS in Manchuria 
during troop field maneuvers, and in the same year the milder form of hantavirus 
disease, nephropathia epidemica (NE), was first described in Sweden (Myhrman, 
1951). During World War II, 10,000 German and Finnish soldiers were infected in 
Finnish Lapland. In the 1950s, HFRS was recognized in countries of Eastern Europe 
including former Yugoslavia, Bulgaria, former Czechoslovakia, and Hungary 
(Gajdusek, 1962). Also during the 1950s, American soldiers met HFRS during the 
Korean War: over 3,000 American and Korean soldiers fell severely ill with a lethality 
of more than 10% (Earle, 1954). In the attempt to identify the causative agent in the 
Korean War, Ho Wang Lee developed a sensitive diagnostic test for clinical HFRS by 
using lung sections from infected wild mice (Lee and Lee, 1976). In the meantime, 
several groups failed to find a susceptible laboratory host or cell system. After Lee 
adapted the infectious agent to mice belonging to the subspecies jejudoica, he 
successfully isolated the first hantavirus, Hantaan virus (HTNV) (Lee et al., 1978). 
Since then more and more HFRS-causing viruses have been identified. Soon in 1980, 
the first hantavirus found in Europe PUUV was identified by Finnish scientists in the 
lungs of infected bank voles (Brummer-Korvenkontio et al., 1980). A number of 
hantaviruses were identified soon after, including Seoul (SEOV) and Prospect Hill 
virus (PHV) in the early 1980s (Lee et al., 1982), Thailand virus in 1985, Dobrava 
(DOBV) in 1992 and Tula (TULV) in 1994 (Avsic-Zupanc et al., 1992; Elwell et al., 
1985; Plyusnin et al., 1994).  
Another important event in hantavirus history was the outbreak in southwestern 
USA in 1993 which initially killed up to 50% of the infected patients. The causative 
agent was soon identified and later named Sin Nombre virus (SNV). Since then, more 
New World hantaviruses have been discovered in North and South America. At 
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present, nearly 50 hantaviruses have been identified including over 20 hantaviruses 
causing human disease (Heyman et al., 2009; Vaheri et al., 2011). 
 
4.3 Virus structure and genome  
Hantaviruses are negative-stranded RNA viruses with a tripartite genome. The 
large (L) segment ( 6.5 kb) encodes the viral RNA-dependent RNA polymerase (L 
protein), the medium (M) segment (3.6-3.7 kb) two surface glycoproteins, Gn and Gc, 
and the small (S) segment (1.7-2.0 kb) the nucleocapsid (N) protein (Plyusnin et al., 
1996). A nonstructural protein (NSs) was found recently in some (e.g. TULV and 
PUUV) but not all hantaviruses, and it is encoded by an overlapping (+1) ORF of the 
S segment (Jääskelainen et al., 2007; Virtanen et al., 2010). Both the 5' and 3' ends 
of each genomic segment contain non-coding sequences (NCR) (Plyusnin, 2002). Due 
to the conserved, complementary terminal nucleotides on the L, M, and S segments, 
hantavirus RNA segments can form closed circular structures called panhandles 
(Plyusnin et al., 1996). 
The hantavirus virion has a varying morphology (Martin et al., 1985). Taking 
TULV as an example, the structure has been recently revealed by electron 
cryotomography: generally they are large spherical particles with a diameter of 
120-160 nm, occasionally smaller particles with a diameter of 60 nm, but there are 
also tubular particles 350 nm long and 80 nm in diameter (Huiskonen et al., 2010).  
The virion surface is covered by Gn and Gc proteins. Only small areas of membrane 
are exposed. The Gn and Gc were recently reported to favor homo-oligomers over 
hetero-oligomers, and Gn and Gc proteins are presented in heterocomplexes that 
include tetramers of Gn protein interconnected by Gc protein dimers forming a unique, 
four-fold grid-like structure on the surface of viral particles (Hepojoki et al., 2010a). 
The virions contain viral ribonucleoprotein complexes (vRNP), which consist of the 
genomic S, M, L vRNA encapsidated by N protein. It has been suggested that the 
bunyavirus vRNPs can interact directly with the viral glycoprotein thus facilitating  
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virus assembly (Hepojoki et al., 2010b; von Bonsdorff and Pettersson, 1975; Wang et 
al., 2010).  
 
4.4 Virus life cycle 
4.4.1 Entry 
Both pathogenic and non-pathogenic hantaviruses can replicate in endothelial 
cells but there is little if any damage to the infected endothelium (Yanagihara and 
Silverman, 1990; Zaki et al., 1995). HTNV
 
and PUUV enter cells from the apical 
surface of polarized endothelial cells (Krautkramer and Zeier, 2008), while the entry 
of Andes hantavirus (ANDV) occurs via both apical and basolateral membranes of 
epithelium cells (Rowe and Pekosz, 2006). Virus entry is initiated by attachment to 
cells. The hantavirus first has to interact directly with host cell receptors. Integrins act 
as host cell receptors mediating the hantavirus entry. 
Integrins are heterodimeric transmembrane receptors composed of a combination 
of α and β subunits, and they can mediate cell-cell adhesion, cell migration and 
extracellular matrix protein (ECM) recognition (Sugimori et al., 1997). Pathogenic 
hantaviruses like SNV, NY-1, PUUV, HTNV and SEOV use β3 integrin whereas 
non-pathogenic hantaviruses such as PHV use β1 integrin (Gavrilovskaya et al., 2002; 
Gavrilovskaya et al., 1998).  
After cell attachment, receptor-mediated endocytosis occurs. During this step, the 
hantavirus enters the cell through the dynamin-regulated clathrin-mediated 
endocytosis pathway (Jin et al., 2002). Hantaviruses are transported to early 
endosomes, and subsequently to late endosomes or lysosomes. Within endosomes, the 
low pH induces the fusion activity of Gc protein, the viral and endosomal membranes 
fuse with each other, and then the ribonucleocapsids are released into the cytoplasm 
(Cifuentes-Munoz et al., 2010; Ogino et al., 2004; Tischler et al., 2005).  
Now, the hantavirus starts to reproduce itself. This process is exclusively 
cytoplasmic and includes several steps: transcription (mRNA synthesis), translation 
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(virus protein synthesis) and replication (vRNA synthesis). 
 
4.4.2 Transcription 
During this step, the positive-strand mRNA is synthesized. For the initiation of 
transcription, two mechanisms are involved: cap-snatching and primer-realign.  
The 5'termini of synthesized mRNAs contain a 5'm7G cap structure. This 
5'm7G cap has important biological functions as it is required by the RdRp to initiate 
the transcription (Braam et al., 1983; Dhar et al., 1980; Plotch et al., 1981) and is 
recognized by the cap-binding complex, eIF4F, for the initiation of translation 
(Richter and Sonenberg, 2005; von der Haar et al., 2004). 
The capped RNA primer is generated from the 5'terminus of host cell mRNA by 
the “cap-snatching” process. This process has been well characterized for influenza 
virus. Based on this knowledge, the PB2 subunit of heterotrimeric RdRp binds to the 
5' caps of host mRNA, then the 5'm7G cap is cut from the host mRNA by the PB1 
subunit of influenza virus RdRp (Guilligay et al., 2008; Sugiyama et al., 2009). In 
contrast to the RdRp of influenza virus which has three subunits, the hantavirus RdRp 
is a large single protein. The La Crosse orthobunyavirus (Bunyaviridae) polymerase 
protein contains endonuclease domain (Reguera et al., 2010), whether the hantavirus 
RdRp also has endonuclease activity is unknown.  
In hantavirus, the 5' and 3' end of vRNA has a triplet of repeats 
(3'-AUCAUCAUC) which is indispensable for the 5'cap to bind and initiate 
transcription (Garcin et al., 1995; Mir and Panganiban, 2010).  The 3'terminus of 
5'caps from the host cell mRNA is a “G”residue which is supposed to basepair with 
one of the C residues at the 3'termini of vRNA template during transcription 
initiation (Garcin et al., 1995). The 5'cap is elongated by RdRp using a 
“primer-realign”mechanism (Garcin et al., 1995). In this model 5' caps aligns  
3'terminus of the viral template through G-C basepairing. Following elongation of a 
few nucleotides, the extended primer realigns with viral RNA so that the G residue of 
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3'termini of 5' caps would be at position -1 (Garcin et al., 1995). The binding of N 




In cells, during the initiation of translation, the mRNA 5' cap interacts with the 
cap-binding complex (eIF4F) and then recruits the 43S pre-initiation cmplex which 
contains the small ribosomal subunit, eIF3 cluster of peptides and initiator methionine 
transfer RNA, eIF2 and GTP (Richter and Sonenberg, 2005; von der Haar et al., 2004). 
The cap-binding complex eIF4F comprises eIF4E, which directly binds to the mRNA 
cap (Richter and Sonenberg, 2005; von der Haar et al., 2004), and eIF4A, which 
contains a DEAD box RNA helicase (Rogers et al., 2002), and eIF4G, which acts like 
a bridge between eIF4E and eIF4A (Mader et al., 1995). The mRNA 5'cap together 
with eIF4F and 43S pre-initiation complex proceed to scan for the start codon AUG. 
When the start codon is recognized, 60S large ribosomal subunit and additional 
factors are recruited and translation begins (Kozak, 1991; Kozak, 1992). 
Viruses use cellular machinery for the translation of viral mRNA. However, there 
are still some differences between the mechanisms adopted by different viruses. Take 
picornaviruses as an example, which contain a cis-acting internal ribosomal entry site 
(IRESs) to enable translation initiation without a cap (Hellen and Sarnow, 2001; Jang, 
2006). In the case of hantavirus genome translation, it was recently reported that the N 
protein may replace the cap-binding complex (eIF4F) during the initiation of 




The complementary copy of vRNA, antigenomic RNA (cRNA) is synthesized 
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from the vRNA. Then the new vRNA is synthesized from the cRNA. The initiation 
mechanisms of cRNA/vRNA and viral mRNA are similar, both utilize a primer- 
realign mechanism (Garcin et al., 1995). But there are some differences between viral 
mRNA and cRNA/vRNA. The 5'termini of cRNA and vRNA are not capped because 
they are initiated by GTP, while the termini of viral mRNA contain a 5'capped 
structure.  
The HTNV genome RNA contains a 5'monophosphate (Garcin et al., 1995; 
Habjan et al., 2008). According to the finding made by Garcin 1995, the genome 
chain is initiated with GTP and a cleavage step occurs after realignment to remove the 
initiating GTP, leaving a monophosphate uridine (Garcin et al., 1995). The enzyme 
which has the ability to remove GTP may be the RdRp of hantavirus. 
 
4.4.5 Virus maturation 
4.4.5.1 Encapsidation 
After the viral genome transcription and replication, the viral mRNA and the 
vRNAs of S, L, M exist in the cytoplasm. The newly synthesized N protein starts to 
encapsidate the cRNA and vRNA, but not the viral mRNA (Hacker et al., 1989; Jin 
and Elliott, 1993). The mechanism for selective encapsidation of vRNA and some 
cRNA by the N protein remains unknown. The viral mRNA is quite different from the 
vRNA in structure and sequence, as vRNAs have panhandle structures, but mRNA not. 
Additionally, vRNA has 5'monophosphate, but mRNA has a 5'm7G cap (Raju and 
Kolakofsky, 1989). These specific sequences or structures have been suggested to 
provide the signal for the N protein to encapsidate the cRNA or vRNA but not the 
mRNA (Severson et al., 1999; Severson et al., 2001; Severson et al., 2005). It has 
been reported that HTNV N protein has a binding preference for its S segment vRNA 
as compared to its binding with the S segment open-reading frame (ORF) or 
nonspecific RNA, thus suggesting that the N protein recognition site resides in the 
non-coding region of HTNV vRNA (Severson et al., 1999). Later, it was reported that 
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the 5' end of the S segment vRNA is necessary and sufficient for the binding reaction 
to occur (Severson et al., 2001). 
 
4.4.5.2 Assembly 
The virion should be assembled after the N protein encapsidates the vRNA. 
Bunyaviruses lack a matrix protein, which in other negative-stranded RNA viruses, 
such as ortho-,  paramyxo- and rhabdoviruses, plays a key role in virus assembly 
(Harrison et al., 2010; Schmitt and Lamb, 2004; Ye et al., 1999). Therefore it was 
suggested that bunyavirus vRNPs can interact directly with the membrane-associated 
viral glycoprotein(s) thus helping the virus assembly (von Bonsdorff and Pettersson, 
1975).  For Uukuniemi virus (genus Phlebovirus), the interaction between vRNPs 
and Gn/Gc proteins was first demonstrated by immunoprecipitation (Kuismanen, 
1984). Later, it was shown that it is the glycoprotein cytoplasmic tail (Gn-CT) of 
Uukuniemi virus that interacts with the vRNP (Overby et al., 2007). For Bunyamwera 
virus (genus Orthobunyavirus) the interaction between RNP and Gn glycoprotein has 
been shown in infectious virus-like particles (Shi et al., 2006). Similarly, in tomato 
spotted wilt virus (genus Tospovirus) direct interaction of the N protein, a key 
component of the vRNPs, and Gn glycoprotein was demonstrated by co-localization 
assay (Ribeiro et al., 2009; Snippe et al., 2007). Recently it has been reported that the 
Tula hantavirus Gn glycoprotein interacts with N protein which might facilitate the 
virus assembly (Hepojoki et al., 2010b; Wang et al., 2010). Also in Tula virion 
tomogram slices, connections from the RNP to the membrane, where the cytoplamic 
tail of Gn protein is located, were occasionally observed (Huiskonen et al., 2010). 
Most recently, the Gn glycoprotein of Crimean Congo Hemorrhagic Fever 
(CCHF) virus, Nairovirus genus Bunyaviridae, was found to interact with RNA, 





The hantavirus M segment encodes two viral glycoproteins Gn and Gc. Gn and 
Gc glycoproteins are co-translationally cleaved from a single precursor at the 
conserved WAASA motif and targeted to Golgi compartment where they are 
processed and transported to the virus assembly site (Lober et al., 2001; Shi and 
Elliott, 2002; Spiropoulou et al., 2003). The maturation of bunyaviruses is thought to 
occur intracellularly in the Golgi complex (Matsuoka et al., 1991; Pettersson, 1991), 
as the glycoproteins of bunyavirus are retained in the Golgi complex, which may 
determine the site of virus assembly. In the case of hantaviruses, there exists a 
discrepancy. It has been reported that the glycoproteins of HTNV (representing Old 
World hantaviruses), SNV and ANDV (New World hantaviruses) accumulate in the 
Golgi complex (Shi and Elliott, 2002; Spiropoulou et al., 2003). For Old World 
hantaviruses, intracellular maturation was observed and the viral envelope was 
derived from budding into the Golgi (Schmaljohn and Nichol, 2007), but according to 
electron microscopy studies the maturation site of SNV and Black Creek Canal 
hantavirus is the plasma membrane (Goldsmith et al., 1995; Ravkov et al., 1997). 
 
 
4.5 Viral proteins  
4.5.1 L protein 
The L protein is the RNA polymerase, which transcribes and replicates the 
genomic RNA. The L segments are of similar size among hantaviruses, varying from 
6530 to 6562 nucleotides (Kukkonen et al., 2005). The transcript of hantavirus L 
segment has a single large open reading frame (ORF) to encode L protein with a 
predicted molecular mass of approximately 250 kDa. The size of L protein of HTNV 
and SEOV has been measured by radiolabeling infected cells and running on 12% 
SDS-PAGE gels to be approximately 200 kDa (Elliott et al., 1984). Later on, by using 
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specific antibody against L protein of TULV and PUUV, the size of L protein was 
measured to be 250 kDa (Kukkonen et al., 2004). 
In hantavirus, the L and N proteins are the only viral proteins required for RNA 
synthesis (Flick et al., 2003). The site of RNA synthesis is localized in the cytoplasm 
(Rossier et al., 1986), but whether this site is associated with membrane is unknown. 
It is well known that the RNA synthesis of all plus-strand RNA viruses is associated 
with membranes (Salonen et al., 2005). Since the N protein is localized in the 
perinuclear region (Kariwa et al., 2003; Kaukinen et al., 2003; Ravkov and Compans, 
2001) and associated with membrane (Ravkov and Compans, 2001), and similarly to 
the L protein (Kukkonen et al., 2004), hantavirus RNA synthesis may also be 
membrane associated. 
 
4.5.2 N protein 
N protein which is encoded by the S segment contains 429-433 aa residues. It 
contains of an N terminal coiled-coil region, central conserved region and C-terminal 
helix-loop-helix region (Alfadhli et al., 2002; Kaukinen et al., 2005) (Fig 1). The N 
terminal and C-terminal region are involved in the N protein oligomerization 
(Alminaite et al., 2006; Kaukinen et al., 2005). The central region contains an 
RNA-binding domain and interacts with cellular proteins such as SUMO and Ubc9 
(Kaukinen et al., 2003; Maeda et al., 2003; Xu et al., 2002). The central domain of N 
protein also binds to the 5'caps of mRNAs (Mir et al., 2008). Furthermore, PUUV N 
protein was shown to interact with Daxx protein, a Fas-mediated apoptosis enhancer, 
and the interaction domain has been mapped to the C-terminus (Li et al., 2002). Yeast 
and mammalian two-hybrid assays revealed that the N-terminal amino acids 100–125 
of SEOV N protein, which represents a critical region for N-N oligomerization, was 
responsible for the interaction with SUMO-1-related molecules such as PIAS1, 









amino acid (1-80) amino acid (81-248) amino acid (249-429)
 
Fig 1 Hantavirus N protein. The N-terminal domain, central domain and C-terminal domain are 
shown. 
 
N is involved in many aspects of the virus life cycle, including encapsidation and 
packaging of viral RNA (Jonsson et al., 2001; Mir et al., 2006; Mir and Panganiban, 
2005; Severson et al., 1999), N protein trafficking (Ramanathan et al., 2007; 
Ramanathan and Jonsson, 2008), viral genome translation (Mir and Panganiban, 
2008), viral genome replication (Flick et al., 2003; Kohl et al., 2004; Osborne and 
Elliott, 2000), modulation of apoptosis (Ontiveros et al., 2010) and modulation of 
immune signaling (Taylor et al., 2009a; Taylor et al., 2009b).  
Some of the functions of N protein have been discussed in the above sections. To 
conclude, the N protein encapsidates both cRNA and vRNA after viral genome 
replication (Hacker et al., 1989; Jin and Elliott, 1993). In the transcription and 
translation process, N protein binds to the 5'caps of cellular mRNAs and protects 
them from degradation in cellular P bodies, replaces the cellular cap-binding complex, 
eIF4F, and augments translational expression (Mir et al., 2008; Mir and Panganiban, 
2008); in the viral maturation step, the N protein binds to the glycoprotein Gn to 
facilitate the budding (Hepojoki et al., 2010b; Huiskonen et al., 2010). 
Recently it was reported that N protein is involved in the tumor necrosis factor 
alpha (TNF-activated host immune response and apoptosis. TNF- is a 
multifunctional cytokine with functions including activation of NF-B and induction 
of apoptosis (Wajant et al., 2003). The plasma levels of TNF- are elevated in HFRS 
patients (Krakauer et al., 1995; Linderholm et al., 1996; Temonen et al., 1996) and 
TNF-producing cells are found in the kidneys and lungs of HFRS and HCPS 
patients (Mori et al., 1999). The N protein interacts with importin-which will 
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transport NF-B to the nucleus to activate downstream immune reponse, thus N 
protein can inhibit the TNF- induced NF-B pathway (Taylor et al., 2009a; Taylor 
et al., 2009b). Also, the N protein interacts with NF-B, sequesters it in the cytoplasm, 
and promotes the inhibitor of NF-B (Idegradation, thus N protein can facilitate 




4.5.3 Gn and Gc proteins 
The M segment of hantaviruses encodes two glycoprotein, Gn and Gc. The Gn 
and Gc are co-translationally cleaved from a precursor (GPC) at the conserved 
sequence WAASA (Shi and Elliott, 2002). The Gn protein consists of an external 
domain, a transmembrane domain and a C-terminal cytoplasmic domain (Fig 2). Gc 
consists of an external domain and a quite short C-terminal cytoplasmic domain. The 
hantavirus Gn is a multifunctional protein: it is involved in many aspects such as virus 
recognition by celluar receptors, virus assembly and fusion with cells. In addition, Gn 
is also involved in the inhibition of both IFN-induction and signaling. Gn-CT of 
NY-1V was found to coprecipitate the N-terminal domain of TRAF3 and disrupt the 
formation of TRAF3-TBK1 complex, thus regulating the RIG-I and TBK-1 directed 
immune response (Alff et al., 2006; Alff et al., 2008). The Gn of both ANDV and 
PHV were shown to inhibit nuclear translocation of STAT-1 (Spiropoulou et al., 
2007). Most recently, it was reported that IFN-β induction is inhibited of coexpression 
of ANDV N protein and GPC and is robustly inhibited by SNV GPC alone. 
Downstream amplification by Jak/STAT signaling is also inhibited by SNV GPC and 




Fig 2. Cytoplasmic tail of hantaviral Gn protein. The upper part shows the glycoproteins (Gn and 
Gc). The transmembrane domains and signal domains are marked in grey. The lower part is the 
alignment of Gn-CT sequences. Zinc finger motifs and immunoreceptor tyrosine-based activation 
motif (ITAM) are marked. 
 
In most RNA viruses, the non-structural proteins are involved in the inhibition of  
innate immunity (Haller et al., 2006). But in the case of hantaviruses, the 
glycoproteins are more likely to be involved in the inhibition of innate immunity 
considering that NSs of TULV and PUUV are weak inhibitors. This unusual feature of 
hantavirus glycoproteins may be related to the conserved cytoplasmic tail of Gn. The 
C-terminal part of Gn-CT of hantavirues contains immunoreceptor tyrosine-based 
activation motif (ITAM) which direct receptor signaling within immune and 
endothelial cells (Geimonen et al., 2003). In addition, the Gn-CT tail contains highly 
conserved zinc finger motifs (Estrada et al., 2009) (Fig 2).  
 
4.6 Hantaviruses and immunity 
4.6.1 Innate immunity 
Immediately after virus infection, the host cell innate immunity is induced to limit 
the virus replication. The host cell recognizes the virus infection through the 
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interaction between pathogen recognition receptor (PRR) proteins and 
pathogen-associated molecular patterns (PAMPs).  
The PRRs are comprised of several groups: Toll-like receptors (TLRs), retinoic 
acid-inducible gene I-like RNA helicases (RLHs), NOD-like receptors (NLRs), 
C-type lectin receptors (CLRs) and AIM2-like receptors (ALRs). 
TLRs are expressed by various tissues and cell types, including macrophages, 
dentritic cells, lymphocytes and tissue parenchymal cells (Kumar et al., 2011). Of the 
13 mammalian TLRs discovered so far, TLR2 and TLR4 are expressed on the cell 
surface while TLR3, TLR7, TLR8 and TLR9 are intracellular and endosomal (Kumar 
et al., 2011). TLR2 and TLR4 recognize viral envelope components, TLR3 recognizes 
dsRNA, TLR7 and TLR8 recognize ssRNA rich in G and U residues, and TLR9 
recognizes dsDNA (Kopp and Medzhitov, 2003; Kumar et al., 2011). TLRs recruit 
TIR domain containing adaptor molecules, like MyD88 and TRIF, and thus activate 
the IRF-3, IRF-7 and NF- B, leading to expression of type I IFNs and cytokines 
(Kumar et al., 2011; Yamamoto et al., 2003). 
RLHs include RIG-I, MDA5 and LGP2 and function independently of TLRs 
(Andrejeva et al., 2004; Yoneyama et al., 2004). RIG-I and MDA5 contain two 
caspase-recruitment domains (CARDs) and a DExD/H-box helicase domain. The 
helicase domains recognize viral RNAs, and CARDs then interact with IPS-I (also 
called MAVS, VISA, and Cardif) which are located in the outer mitochondrial 
membrane (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005). 
This interaction then activates IRF-3, IRF-7 and NF-B for the induction of type I 
IFNs and cytokines (Kumar et al., 2011; Sato et al., 2000). LGP2, which lacks the 
CARDs, functions as a positive regulator of virus recognition and subsequent antiviral 





Fig 3. Endosomal and cytoplasmic pathways for virus recognition and IFN production. TLR7 and 
TLR8 recognize viral ssRNA and signals through MyD88 thus activating IFN response. TLR3 
recognize dsRNA and through TRIF activates IFN response. RIG-I and MDA-5 recognize  
ssRNA, dsRNA and via TBK-1 thereby also activating IFN response. Modified from Baum and 
Garcia-Sastre et al., 2010. 
 
The PAMPs include various viral inducers. Nucleic acids derived from virus, 
including dsRNA, ssRNA and DNA, serve as the major PAMPs. From the study of 
chemically synthesized nucleotides, long dsRNA activates MDA5 (Gitlin et al., 2006; 
Kato et al., 2006), and short poly I:C (200-1000 nt) has been reported to trigger RIG-I 
(Kato et al., 2008), and 25 nt to 70 nt long synthetic double-strand RNA lacking 
5'ppp can activate RIG-I (Kato et al., 2008; Takahasi et al., 2008). Another effector is  
5'ppp RNA. The genomic RNA of influenza or rabies viruses bearing 5'ppp, but not 
genome of viruses that have a 5'monophospate, can activate the RIG -I dependent 
IFN induction (Habjan et al., 2008; Hornung et al., 2006; Pichlmair et al., 2006). Also 
it has been reported that the recognition of 5'ppp by RIG-I requires short blunt 
double-stranded RNA which is inconsistent with other reports (Schlee et al., 2009; 
Takahasi et al., 2008).  
Although the activity of natural RNAs after infection is largely unknown, there is 
evidence that the antigenomic RNA of negative-stranded viruses, which bears 5'ppp, 
contributes only minimally to RIG-I activation compared to the genomic RNA also 
bearing 5'ppp (Rehwinkel et al., 2010). The mRNA transcripts of measles and 
Epstein-Barr viruses bearing 5'ppp termini are reported to activate RIG-I (Plumet et 
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al., 2007; Samanta et al., 2006). A viral mRNA, with 5'-cap and 3'-poly (A) was 
found to activate IFN expression through the RNase L-MDA5 pathway (Luthra et al., 
2011). The panhandle structure of negative-stranded RNA virus genome is also 
thought to be a RIG-I inducer (Schlee et al., 2009).  
Except the viral RNA, the PAMPs include viral proteins and ribonucleoprotein 
(RNP) complex. The RNPs of the negative-stranded vesicular stomatitis and measles 
viruses were found capable of triggering IFN induction (tenOever et al., 2002; 
tenOever et al., 2004). Hepatitis C virus (HCV) NS5A protein has been shown to 
activate NF-B when expressed in cells (Waris et al., 2002). 
 
4.6.1.1 Hantaviruses and innate immunity 
4.6.1.2 Induction of innate immunity by hantaviruses 
In the 1990s, it was reported that PUUV-infected monocyte/macrophages 
produce significantly increased amount of MxA, suggesting IFN- production 
(Temonen et al., 1995). In microarray assay, upregulated interferon regulatory factor 
(IRFs) gene expression level was observed in both SNV-infected cells and 
PHV-infected cells, no changes of IFN- gene expression were observed 
(Khaiboullina et al., 2004). In another mircroarray screening, it was found that PHV 
induced much higher expression of MxA and 24 IFN-specific genes 24 h post 
infection than NY-1V and HTNV, but at late times MxA was induced about 200 fold 
by all three hantaviruses (Geimonen et al., 2002). A study comparing innate immunity 
induction of HTNV and TULV-infected HUVEC cells showed that HTNV induced a 
higher interferon response than the non-pathogenic TULV hantavirus, while TULV 
showed an early onset of MxA expression compared to HTNV (Kraus et al., 2004). A 
comparison between PHV and ANDV disclosed that PHV, but not ANDV, induced a 
robust interferon (IFN- response early after infection, and IRF-3 dimerization and 
nuclear translocation was detected in PHV but not ANDV infection (Spiropoulou et 
al., 2007). ANDV and SNV infection elicited minimal or delayed expression of 
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ISG56 and MxA in A549 and Huh-TLR3 cells (Levine et al., 2010). Recently, it has 
been reported that the activation of complementary system is in correlation with the 
disease severity in PUUV infection patients (Sane et al., 2011). 
Although there are inconsistences in the above reports, we can conclude that most 
hantaviruses can activate the innate immunity, however, pathogenic HTNV, NY-1 
and ANDV may lead to a lower induction probably due to the fact that the pathogenic 
hantaviruses can evade the innate immunity.  
Several groups have studied the mechanism of the induction of IFN innate 
immune response to hantaviruses.  
It has been reported that the IFN innate immune responses to SNV are 
independent of virus entry, IRF-3, TLRs, and other known PRRs in infected Huh7 
cells (Prescott et al., 2007). In contrast to the results, recently the same group reported 
that the intial activation of innate immunity in SNV infected Huh7 cells was due to 
the IFN- contained in the SNV virus stock, and Huh7 cells lack the innate immune 
responsiveness to SNV (Prescott et al., 2010). Also, UV-inactivated PHV, ANDV and 
HTNV were unable to induce innate immunity, and TLR3 was needed for HTNV to 
trigger innate immunity induction (Handke et al., 2009; Spiropoulou et al., 2007). But 
interestingly, UV-inactivated SNV can still activate the innate immunity response at 
early time points post infection in HUVEC cells and the initial immnunity response in 
SNV-infected HUVEC was not due to IFN- contained in the SNV stock (Prescott et 
al., 2010; Prescott et al., 2005). It has been reported that dsRNA is not detectable in 
negative-stranded RNA viruses, and RIG-I is unable to detect genomic RNA derived 
from HTNV (Habjan et al., 2008; Weber et al., 2006). In conclusion, what PAMPs 
and PRRs are involved still remains unknown; different hantaviruses may use 





While host cells utilize the innate immune response to limit virus replication, 
viruses have evolved numerous ways to escape the interferon response. The Gn-CT of 
NY-1, but not PHV, blocks RIG-I and TBK-1 directed IFN- responses by interacting 
with TRAF3 and thus disrupting TBK-1-TRAF3 complex formation (Alff et al., 2006; 
Alff et al., 2008). In contrast to this result, the full-length glycoprotein of ANDV and 
PHV was found unable to inhibit IRF-3 activation by Sendai virus, but instead 
inhibited the Jak/Stat interferon signaling pathway (Spiropoulou et al., 2007). In line 
with this, another group reported that the N protein and GPC of ANDV did not result 
in inhibition of IFN induction seperately, but when N and GPC of ANDV were 
expressed together there was an inhibitory effect on IFN induction (Levine et al., 
2010). IFN induction was inhibited robustly by GPC of SNV alone, and the IFN 
amplication by Jak/Stat signaling was inhibited by SNV GPC and by either N or GPC 
of ANDV (Levine et al., 2010). Moreover, the NSs of TULV and PUUV was found to 
act as a weak inhibitor of IFN response (Jääskelainen et al., 2007; Jääskelainen et al., 
2008). In conclusion, different hantaviruses may use different mechanisms to inhibit 
the innate immunity response, and this mechanism appears to be independent of virus 
pathogenicity in humans. 
 
4.6.2 Adaptive immunity 
While the innate immunity serves as a first line defense system in nearly all 
multicellular organisms, the adaptive immunity functions as a more sophisticated, 
specific and longer-lasting immune system. The adaptive immunity consists of 
humoral immune response which involves antibody secretion by B cells and the 




4.6.2.1 Humoral immune response and diagnostics  
Antibodies produced by B lymphocytes include IgA, IgG, IgE, IgM and IgD. 
These antibodies circulate around the body in the blood and are present in other body 
fluids, where they can recognize and eliminate antigens or pathogens. 
After hantavirus infection, the virus elicits a stable and long-lasting humoral 
immune response involving all Ig classes. IgA is an antibody produced in the mucosa. 
In ANDV- and PUUV- infected patients the level of total and specific IgA has been 
reported to be elevated (de Carvalho Nicacio et al., 2001; Padula et al., 2000). IgE 
triggers the immediate allergic reations. The total IgE level was increased in patients 
with HFRS (Alexeyev et al., 1994). The virus-specific IgM directed against all three 
structure proteins (N, Gn, Gc) are present during the early phase of the disease and at 
decreasing levels during convalescence (Lundkvist et al., 1993). ELISA test based on 
recombinant N protein to detect hantavirus specific IgM is the most commonly used 
technique in diagnostics (Kallio-Kokko et al., 1998; Sjolander et al., 1997; Vapalahti 
et al., 1996). For PUUV diagnosis, besides the traditional immunofluorescence assay, 
a -capture enzyme immunoassay for IgM has been used routinely, and a 
point-of-care test for acute PUUV has been developed based on IgM detection 
(Hujakka et al., 2001; Vapalahti et al., 1996). IgG is the major class of circulating 
antibodies, and N proteins are the major target antigens followed by Gn and Gc 
(Kallio-Kokko et al., 2001; Vapalahti et al., 1995).  
Different hantaviruses have different epitope patterns, the cross-reactive epitope 
of HFRS virus N proteins was located within the first 118 amino acid N-terminal 
residues and the serotype-specific epitopes were located in the middle of the protein 
(Gott et al., 1997; Yoshimatsu et al., 1996). The Gn and Gc proteins also contain 
epitope regions, e.g. in SNV there is a serotype-specific epitope located at 59-89 aa 
from N termninus (Jenison et al., 1994). Both PUUV Gn and Gc contain at least one 




4.6.2.2 Cellular immune response 
T lymphocytes together with natural killer cells, dendritic cells and macrophages 
can produce various cytokines or directly act on the pathogens. T lymphocytes play an 
important role in the pathogeneses of HFRS and HCPS. Upon hantavirus infection, 
the levels of IFN-, TNF-, IL-2 and IL-6 are increased, the amount of CD8+ cells is 




 ratio was detected (Linderholm et al., 
1996). Also higher frequencies of SNV-specific T cells were found in patients with 
severe HCPS (Maes et al., 2004) which indicates that a higher amount of CD8
+
 
correlated with more severe symptoms of the disease. Interestingly, human CD8
+
 T 
cells are generated during the acute phase of PUUV-HFRS, and these memory C8
+
 
cells persist for 15 years after the acute phase without virus persistence (Tuuminen et 
al., 2007; Van Epps et al., 2002). These reports suggest that immunopathogenesis may 
have a role in the clinical syndrome caused by hantavirus infection. The natural killer 
(NK) cells also take part in the innate and adaptive immunity. After hantavirus 
infection changes in NK cells population were observed according to several reports, 
but the results are controversial. Significantly higher numbers of NK cells were 
observed in NE and HCPS patients (Linderholm et al., 1993; Nolte et al., 1995), 
whereas another group found no changes or decreased numbers (Lewis et al., 1991). 
Most recently it was reported that the NK cells expanded rapidly and remained at 
significantly elevated numbers for over two months (Bjorkstrom et al., 2011). 
Dendritic cells are the most important antigen-presenting cells. These cells can be 
infected by hantaviruses and the infection can upregulate the MHC (HLA), 
costimulatory and adhesion molecules (Raftery et al., 2002). HLA is expressed as a 
cell-surface antigen presenting protein, and is composed of two classes. HLA I is 
expressed in most cells and presents peptides from inside cells, thus directing CD8 
cells to destroy the presenting cell. HLA II is expressed only by antigen-presenting 
cells and can attract CD4 cells. Several groups reported the association of HLA with 
susceptibility to hantavirus infection. HLA-B*3501 and B8-DRB1*03 were 
associated with severe symptoms of HCPS and NE while HLA-B27 was linked to 
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mild course of PUUV infection (Kilpatrick et al., 2004; Makela et al., 2002; 
Mustonen et al., 1996; Mustonen et al., 1998). Like the B cell epitopes, the N protein 
is the major viral target antigen for T cells, but Gn and Gc also have epitope regions 




5 Aims of the study 
Hantaviruses have four structural proteins Gn, Gc, L and N. Each protein has its 
unique functions during virus replication. Our aim was to study the functions of Gn 
protein from different aspects, synthesis and degradation (I), interaction with N 
protein (II), and role in innate immunity (IV). In addition, we were interested in how 
the hantavirus activate IFN innate immunity.(III). The specific aims of each study 
were: 
I   To study the degradation and aggresome formation of Gn protein. 
II  To study the interaction between hantavirus Gn protein and N protein. 
III and IV  To study the mechanisms of IFN immune response induction and evasion 





6 Materials and Methods 
Cell cultures and reagents (I - IV) 
Human embryonic kidney cells (HEK-293), African green monkey kidney 
epithelial cells (Vero E6) and human lung adenocarcinoma epithelial cells (A549) 
were maintained in modified Eagle's medium (MEM). 10% fetal bovine serum, 2 mM 
glutamine, 100 IU penicillin/ml and 100 µg streptomycin/ml were added into the 
medium. All cultures were grown at 37℃ in a humidified atmosphere containing 5% 
CO2. 
 
Virus infection and purification (III)  
Different viruses have been used including PUUV, TULV, DOBV, SEOV, 
SAAV and Semliki forest virus (SFV). All handling of live virus was performed in a 
laboratory of biosafety level 3 or 2. For infection, desired amounts of viruses were 
added to cell monolayers for absorption for 1 hour at 37℃, virus inocula were then 
removed and replaced with complete medium.  
For virus purification, growth medium collected 7-14 days after infection was 
cleared through a 0.22-m pore-size filter (Millipore), and virus particles were 
concentrated by pelleting through a 3-ml 30% (wt/vol) sucrose cushion (Beckman 
SW28 rotor; 27,000 rpm for 2 h at 4°C) in 10 mM HEPES, 100 mM NaCl, pH 7.4 
buffer.  
 
Plasmid constructions and transfections (I, II, IV)  
By using different programs (HMMTOP, TMHMM, SOSUI AND TMPRED) 
(Hirokawa et al., 1998; Hofmann and Stoffel, 1993; Krogh et al., 2001; Tusnady and 
Simon, 2001), the region of Gn-CT was chosen (aa residues 521 to 653). TULV, 
PUUV and PHV Gn-CT were fused in-frame with enhanced GFP (eGFP) in the 
peGFP-C1 (Clontech) vector. The TULV Gn-CT was also fused with pCMV-HA 
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(Clontech). The TULV Gn-CT proteins, lacking 21 or 34 residues from the C 
terminus, were fused to eGFP in the peGFP-C1 vector. The expression plasmids for 
GST-tagged TULV Gn-CT and truncated TULV Gn-CT were constructed by inserting 
PCR fragments into the pGEX-4T-3 vector (GE Healthcare). The N protein of TULV 
was cloned into pcDNA3 (Invitrogen) plasmid and pCMV-HA plasmid. Point 
mutations were introduced into pGEX-4T-3-CT and pcDNA3-TULV-N plasmids 
using a site-directed mutagenesis kit (Stratagene) according to the manufacturer's 
instructions. Lipofectamine 2000 (Invitrogen) and TranIT (Mirus) transfection reagent 
were used to transfect vectors into cells according to the manufacturer's instructions. 
 
 
Immunoblotting (I, II,IV) 
Cells were collected and lysed in radioimmunoprecipitation buffer (150 mM 
sodium chloride, 50 µM Tris/HCl pH 7.5, 0.2% SDS, 0.5% deoxycholate, 1% NP-40). 
Ten micrograms of total protein from each sample were run on 12% SDS-PAGE and 
electroblotted on to a nitrocellulose membrane. Proteins were probed with a primary 
antibody followed by three washes with TENT buffer (0.05% Tween 20; 20 mM 
Tris-HCl; pH 8, 1 mM EDTA; 50 mM NaCl). Then the secondary antibody was used 
to blot the proteins. After three washes with TENT buffer the proteins were detected 
by enhanced chemiluminescence.  
 
Immunofluorescence and confocal microscopy analysis (I, III) 
Cells were grown on coverslips in 24-well plates and transfected with different 
constructs. Later, the cells were washed and fixed with 3.5% paraformaldehyde in 
PBS for 20 min at room temperature, permeabilized and blocked with 3% BSA and 
0.1% Triton X-100 in PBS. The cells were stained with primary antibody for one hour, 
then washed three times with PBS, stained with fluorescein-conjugated secondary 
antibodies, and observed under a fluorescence or confocal microscope (Leica SP2).  
 
Antibodies and reagents (I, II, III) 
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Primary antibodies: Anti-green fluorescent protein (GFP) (Sigma); anti-β-actin 
primary antibody (Sigma); anti-hemagglutinin (HA) (Abcam); mouse anti-vimentin; 
mouse anti--tubulin (from Erkki Hölttä, University of Helsinki); TULV N specific 
monoclonal antibodies (MAb) 1C12 (from Ake Lundkvist, Stockholm); anti-FLAG 
antibodies (Sigma); mouse monoclonal antibody J2 (Scicons); patient serum against 
PUUV (local); antibody against SFV (anti-SFV) (from Ari Hinkkanen, University of 
Kuopio). 
Secondary antibodies: anti-mouse IgG red-fluorescent Alexa Fluor 555 
(Invitrogen); anti-mouse HRP (DAKO); anti-mouse Dylight680 conjugate (Pierce 
Biotechnology); FITC-labeled anti-human IgG (DAKO); FITC-labeled anti-rabbit 
IgG (DAKO). 
Reagents: proteasomal inhibitors MG-132, ALLN, lactacystin and protein 
synthesis inhibitor cycloheximide (CHX) (Sigma); Sepharose 4B glutathione beads 
(GE Healthcare); calf intestinal alkaline phosphatase (CIP) (Finzyme); 
5'-phosphate-dependent exonuclease (Epicentre Biotechnologies). 
 
Flow cytometry protocol (I). 
Cells were transfected with eGFP-TULV-Gn-CT and treated overnight with 25 
µM ALLN. Cells were collected, fixed with 3% paraformaldehyde (PFA) and washed 
with PBS. The percentage of GFP-positive cells after various treatments was 
calculated using flow cytometry (The Flow Cytometry Facility, Haartman Institute, 
University of Helsinki).  
 
GST pull-down assay (II) 
E. coli (BL21) transformed with GST-tagged Gn-CT constructs were grown in 
300 ml of LB medium containing 0.1 mg/ml ampicillin. When the value of A600 
reached 0.6, the bacteria were induced with 1 mM 
isopropyl--D-1-thiogalactopyranoside (IPTG) for 5 h and then harvested by 
centrifugation at 7000 × g for 10 min and resuspended in lysis buffer (10 mM Tris pH 
35 
 
8.0, 150 mM NaCl, 50 mg/ml lysozyme, with or without 1 mM EDTA). After addition 
of 5 mM dithiothreitol and 1.5% N-lauroylsarcosine, cells were sonicated briefly and 
lysates were cleared by centrifugation at 10,000 × g for 5 min at 4°C. Supernatant was 
adjusted to 2% Triton X-100, incubated at 4°C for 1 h and bound to Sepharose 4B 
glutathione beads (GE Healthcare). Beads were washed three times for 10 min with 
cold STE buffer (10 mM Tris pH 8.0, 150 mM NaCl with or without 1 mM EDTA). 
Precleaned HEK 293-cell lysates which express the N protein were incubated 
with slurry of GST-bound Sepharose 4B glutathione beads overnight at 4°C with 
end-over-end mixing and the beads were washed five times with 1 ml of ice-cold ST 
buffer (10 mM Tris pH 8.0, 150 mM NaCl). Supernatants and beads were then mixed 





Primer Nucleotide sequence Target gene, and 
expected size (bp) 
SEOMF1936 GTGGACTCTTCTTCTCATTATTG SEOV, M gene, 417 
SEOMR2353 TGGGCAATCTGGGGGGTTGCA  
DOBV/SAAVMM1674F TGTGAI(A/G)TITGIAAITAIGAGTGTGA DOBV, SAAV, M 
gene, 316 
DOBV/SAAVMM1990R TCIG(A/C)TGCI(G/C)TIGCIGCCCA  
PUUVSF532 TCATTTGA(A/G)GA(G/T)ATCAATGGCAT PUUV, S gene, 665 
PUUVSR1197 CCCATTCCAACATAAACAGTAGG  
TULVSF894 GATTGATGACTTGATTGATCTTGC TULV, S gene, 473 
TULVSR1367 ATGTGTRTGTGTGTATGCAGGAAC  
FLUMF25 AGATGAGTCTTCTAACCGAGGTCG Influenza A, M gene, 
349 
FLUMR324 TGCAAAAACATCTTCAAGTCTCTG  




Reverse transcription was performed with 1 l RevertAid M-MuLV Reverse 
Transcriptase (Fermentas) and 0.5 g random hexanucleotides in 20 l reaction 
mixture include 0.5 l RNase inhibitor and 1mM dNTP. The resulting cDNA was 
amplified by 30 cycles of PCR, with each cycle consisting of 1 min at 95℃, 1 min at 
50℃, and 1 min at 72℃, followed by a final step for 10 min at 72℃. 
 
Reporter gene assay (III, IV) 
Subconfluent HEK-293 cell monolayers grown in 24-well dishes were transfected 
with 0.15 g of IFN-promoter luciferase reporter construct (p125-Luc) and 0.5 ng 
of constitutively active Renilla luciferase expression vector (pRL-SV40) in 50 l 
OptiMEM (Gibco-BRL) using 3 l Lipofectamine 2000 (Invitrogen) per g DNA. 
After 6 h at 37°C, cells were transfected either with 0.5 g of viral RNA or with 0.5 of 
g poly I:C using 3 l Lipofectamine 2000 (Invitrogen) per g RNA prepared in 50 l 
OptiMEM. At 18 h post transfection, the luciferase activities were determined using 
the Dual-Luciferase Reporter Assay System (Promega) and multilabel reader (Wallac). 
(III)  
HEK-293 cells (20,000 cells/well) were seeded in 96-well plate and were 
cotransfected on the following day with p125-Luc60 ng), pRL-SV40 (60 ng), 
indicated amount of viral protein expression vectors and also 60 ng of expression 
construct which can activate innate immune pathway including TBK-1 construct, 
RIG-I construct, MyD88 and IRF-7 constructs, TRIF construct, IKK and IRF-3 
constructs (from Illka Julkunen, KTL). The transfection was done following the 
manufacturer's instructions of TransIT tranfection reagent (Mirus). The total amount 
of plasmid transfected was kept constant by using empty vector (peGFP-C1 or 
pCMV-HA). At 24 hours posttransfection luciferase activities were determined using 







7.1 Fate of Gn-CT of the apathogenic Tula hantavirus and its role in virus 
assembly 
7.1.1 Degradation and aggresome formation of Gn-CT (I) 
The Gn-CT of TULV is proteasomally degraded 
To determine whether the Gn-CT of TULV is proteasomally degraded, TULV 
Gn-CT (residues 521 to 653) was fused to the C-terminus of enhanced green 
fluorescent protein (eGFP). HEK-293 cells, transfected with this construct, were 
treated with proteasome inhibitors (ALLN, lactacystin, MG-132) separately. 
Proteasome inhibition is known to stabilize proteins that are destined for degradation 
by the proteasome (Coux et al., 1996). The expression level of eGFP-TULV-Gn-CT 
was nearly undetectable when the cells were treated with DMSO, but increased after 
treatment with proteasomal inhibitors (I, Fig. 2A).  
To define whether the TULV Gn-CT colocalizes with ubiquitin which is known to 
be associated with degrading proteins, eGFP-TULV-Gn-CT and hemagglutinin 
(HA)-tagged ubiquitin were cotranfected into HEK-293 cells. Twenty-four hours later 
the cells were treated with DMSO or proteasome inhibitor ALLN overnight. Ubiquitin 
was detected by staining with anti-HA antibody. Confocal microscopy was used to 
study the colocalizaton of the these two proteins. Colocalizaton was observed when 
the cells were treated with the proteasomal inhibitor, while partial colocalization was 
seen when they were DMSO treated (I, Fig. 2B).  
To check whether the degradation signal resides within the C-terminus of TULV 
Gn-CT, TULV Gn-CT protein lacking 21 or 34 residues from the C-terminus were 
fused to eGFP. HEK-293 cells were transfected with these constructs or the full-length 
eGFP-Gn-CT. 24 hours after transfection, the cells were treated either with 25M 
ALLN or DMSO overnight. The deletion of 21 or 34 residues from the C-terminus 
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completely stabilized the protein expression (I, Fig. 2C).  
These results suggest that the Gn-CT of TULV is directed to degradation through 
the ubiquitin-proteasome pathway and that the C-terminal 21 residues of TULV 
Gn-CT are required for the proteasomal degradation.  
 
The Gn-CT of other apathogenic and pathogenic hantaviruses is degraded by 
proteasomes 
HEK-293 cells were transfected with eGFP-PHV Gn-CT and eGFP-PUUV 
Gn-CT, and treated with MG132 or ALLN separately as described above. 
Unexpectedly, the PHV hantavirus Gn-CT was also degraded (I, Fig. 3), which 
contradicts a previous reports (Sen et al., 2007) while the PUUV Gn-CT was 
degraded, as expected (I, Fig. 3).  
Furthermore, another cell line was used to test the degradation property of TULV, 
PHV and PUUV Gn-CT. Vero E6 cells were transfected with eGFP-TULV-Gn-CT, 
eGFP-PHV-Gn-CT and eGFP-PUUV Gn-CT, and the cells treated with DMSO, CHX, 
MG132, or MG132+CHX. Similarly, the Gn-CT of PHV, TULV and PUUV were 
degraded in VeroE6 cells and the tail protein level was maintained by continuous 
synthesis and rapid degradation (I, Fig. 4). 
In addition, we compared the results from the two different cells described above 
by performing FACS assay. Vero E6 and HEK-293 cells transfected with eGFP-TULV 
Gn-CT and were treated overnight with 25 M ALLN. The percentage of 
GFP-positive cells calculated using flow cytometry further confirmed our previous 
result that the Gn-CT of TULV was not degraded when treated with proteasome 
inhibitors (I, Fig. 5).   
 
TULV Gn-CT forms aggresomes upon treatment with proteasomal inhibitor  
fter treatment with proteasomal inhibitor, we found that TULV Gn-CT  formed 
aggresome-like structure. Further, we found that the TULV Gn-CT protein colocalized 
with -tubulin, an microtubule-organising centre (MTOC) marker, after treatment with 
ALLN (I, Fig. 6A). Since aggresome formation is dependent on transport along 
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microtubules, nocodazole can inhibit the formation of aggresomes leading to the 
dispersion of aggregates throughout the cytoplasm. HEK-293 cells transfected with 
eGFP-Gn-CT were treated overnight with DMSO, 25 M MG-132 and/or 1g/ml 
nocodazole (NOC). Cells were observed under a fluorescence microscope. The 
treatment of transfected HEK-293 cells with nocodazole together with MG-132 
prevented the formation of MG-132-induced accumulation of TULV Gn-CT protein 
into aggresomes and instead induced the dispersion of these structures diffusely to the 
cytoplasm (I, Fig. 6B). The percentage of large aggresome-containing cells in 
nocodazole and MG-132 treated samples was lower than in cells treated only with 
MG-132 (I, Fig. 6C). These results showed that, when overexpressed, TULV Gn-CT 
translocated to the aggresomes formed. 
 
7.1.2 Interaction between Gn tail and N protein (II) 
First, the interaction between Gn-CT and N protein was studied. The Gn-CT was 
expressed as a GST-fusion protein in E. coli and bound to glutathione beads (II, Fig. 2 A). 
The N protein was expressed in HEK-293 cells (II, Fig. 2 B). To establish the GST 
pull-down assay, we observed the pull-down of N protein with the Gn-CT in different 
dilutions of the initial N protein-fractioning lysate (II, Fig.3). Notably, the treatment of 
the N protein-containing lysates with RNase (that left no cellular RNA of any substantial 
length intact) did not influence the efficiency of pull-down assay (II, Fig. 4 A, 4 B). This 
suggested that, to interact with the Gn-CT in these experimental settings, the N protein 
does not need to be a part of long RNP structures formed via nonspecific encapsidation of 
cellular RNA.  
 
Analysis of the Gn-CT/N interaction: cytoplasmic tail of the Gn protein  
  We analyzed the two structure-functional elements within the Gn-CT: zinc finger 
motifs and ITAM motifs. As known, EDTA can chelate Zn
2+
 cations thus disrupting the 
structure of zinc fingers. The standard buffer used in experiments described in II, Fig. 3 
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contained 1 mM EDTA. Therefore, in subsequent experiments EDTA was omitted from 
all buffers and the beads with attached Gn-CT were treated with 100 M ZnSO4. We 
found that the amount of pulled-down N protein in ZnSO4-treated samples was 
substantially higher than in EDTA-treated samples thus suggesting that the concentration 
of Zn
2+ 
cations is important for the Gn-CT/N interaction (II, Fig. 5 A).  
Next, zing finger motifs were destroyed by point mutations, and the resulting 
constructs were analyzed in the modified pull-down assay (EDTA omitted and the 
Gn-CT-beads treated with ZnSO4). The results showed that both zinc fingers should stay 
intact for successful pull-down (II, Fig. 5 B). Introduction of H->Q and C->S mutations 
in two HxxxC motifs (H566Q,C570S); (H592Q,C596S) totally abolished the Gn-CT/N 
interaction, and the double hit (C575S,C578S,H592Q,C596S) abolished the interaction as 
well.  
Two deletion mutants were made to partially/totally destroy the conserved ITAM 
motifs in the Gn-CT. In one of the mutants 21 C-terminal aa residues, which included the 
second YxxL-sequence, were deleted. In another mutant, GST-CTΔ34, both ITAMs were 
deleted. Both mutants with deletions retained the capability to pull-down the N protein 
(Fig. 5 C). Taken together, these results indicated that zinc finger motfs but not ITAM 
motifs are crucial for its interaction with the N protein. 
 
Analysis of the Gn-CT/N interaction: the N protein  
The N-terminal domain (aa 1-79) and C-terminal domain (aa 370- 429) of hantaviral 
N protein are involved in oligomerization. The central part of the N protein is thought to 
carry the RNA-binding domain (Fig 1). To find out which domain in the N protein is 
involved in the interactions with the Gn-CT, several N protein mutants were tested in the 
pull-down assay (II, Fig. 1 B). First, several mutations and deletions were made to 
evaluate the role of the C-terminus of N protein in the Gn interaction (NΔC25 (N1-404), 
NΔC31 (N1-398), NΔC100 (N1-329), and two point mutants, I380A,I381A and W388A). 
None of the deletions and mutations affected the ability of the N protein to be 
pulled-down (II, Fig. 6 A; only some of the results are shown).  
Another three deletions were made to evaluate the possible contribution of the 
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N-terminal and central N protein domains; three more constructs were created (N(D1), 
N(D2), N(D1D2)) (II, Fig. 2 B). Of these three proteins, only D1 (aa 1-79) could not be 
pulled-down (II, Fig. 6 B). 
These results showed that the D2 (aa 80-248) domain which is the central domain of 
N protein is both critical and sufficient for the interaction with Gn-CT.  
 
7.2 Regulation of interferon response by Old World hantaviruses 
7.2.1 Viral dsRNA production and genomic RNA of hantavirus (III) 
There are no detectable amounts of dsRNA in cells infected with hantaviruses  
The presence of dsRNA in hantavirus-infected Vero E6 cells was detected by  
dsRNA-specific mouse monoclocal antibody J2. Cells infected with different 
hantaviruses (SEOV, DOBV, SAAV, PUUV, TULV) or Semliki forest virus (SFV) 
were stained with J2 antibody and virus specific antibody. Strong dsRNA signals were 
observed in the cells transfected with poly I:C and also in the cells infected with SFV. 
In contrast no dsRNA was detected after SEOV, DOBV, SAAV, PUUV or TULV 
infection (III, Fig. 1). Meanwhile, all these viruses replicated efficiently as shown by 
the expression of viral protein. Thus, hantavirus-infected cells did not produce any 
detectable amounts of dsRNA. 
 
Hantavirus genomic RNAs contain 5'monophosphate and can not activate 
RIG-I-dependent IFN- induction 
SEOV, DOBV, SAAV, PUUV and TULV viruses were purified and their viral 
genomic RNAs were isolated. The viral RNAs were incubated with exonuclease for 
four hours or were mock treated. This 5'-3'-exonuclease specifically digests ssRNA 
bearing 5'-monophosphate. RT-PCR was performed to detect viral RNAs with and 
without exonuclease treatment. We found that the genomic RNA of influenza A virus 
could still be detected after digestion while the genomic RNAs of  SEOV, DOBV, 
SAAV, PUUV and TULV were degraded which suggested that the 5’-termini of all 
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hantaviruses tested are 5’-monophosphorylated (III, Fig. 2). 
The IFN-promoter reporter gene assay was also used in the experiments. The 
transfection of genomic RNAs of SEOV, DOBV, SAAV, PUUV and TULV did not 
cause any IFN-induction (III, Fig. 3). 
 
7.2.2 Hantavirus Gn-CT inhibits the activation of IFN- immune response (IV) 
TULV Gn-CT but not N protein inhibits TBK-1-directed IFN activation. 
HEK-293 cells grown in 96-well plates were cotransfected with constitutively 
active TBK-1 construct and IFN- promoter reporter construct. Cotransfection with 
pCMV-N expressing HA-tagged N protein had no effect on TBK-1 directed 
IFN-transcriptional activation, while the expression of GFP tagged Gn-CT inhibited 
IFN-transcription and increasing amounts of Gn-CT protein resulted in decrease in 
IFN-transcription (IV, Fig. 1). These results indicate that the TULV Gn-CT but not 
the N protein can inhibit the TBK-1 directed IFN-activation. In addition, the Gn-CT 
fused with different tags was tested. Cotransfecting cells with constitutively active 
TBK-1, RIG-I construct and pCMV-CT resulted in a decrease in TBK-1 and RIG-I 
directed IFN-activation (IV, Fig. 2 A and 2 B) 
 
TULV Gn-CT can inhibit TRIF-, MyD88/IRF-7- and IKK-directed IFN activation but 
not IRF-3-directed IFN activation 
The PRRs are comprised of two main groups: the Toll-like receptors (TLRs) and 
retinoic acid-inducible gene I-like RNA helicases (RLHs). The above results showed 
that the RLH pathway was inhibited by Gn-CT. Most TLRs recruit MyD88 to transmit 
the immunity response while TLR3 signaling is through the recruitment of TRIF. To 
investigate whether Gn-CT is involved in the inhibition of the TLR pathways, 
MyD88/IRF-7 expression construct or TRIF construct were cotransfected with 
pCMV-CT. As shown (IV, Fig. 3a and 3b), the expression of pCMV-CT inhibited IFN 
activation in a dose dependent way. These results suggest that Gn-CT is not only 
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involved in the inhibition of RLH pathway but also TLR pathway.  
To further identify the downstream target of Gn-CT, we used constitutively active 
IKKand IRF-3 constructs. IKKtogether with TBK-1 are two kinases that have 
been demonstrated to directly phosphorylate and activate IRF-3 and IRF-7. As shown 
(IV, Fig. 3c and 3d), Gn-CT inhibited the IKKdirected but not IRF-3 directed IFN 
activation. Taken together, these results suggest that TULV Gn-CT inhibit IFN 
transcriptional activation upstream of IRF-3 phosphorylation and at the level of 






8.1 Analysis of the Gn protein sequence alignment and the selection of Gn-CT 
region  
Based on the sequence analysis of hantavirus Gn protein (Fig 2), the region 521-653 
aa was selected as the Gn-CT and used in projects I, II, IV. As shown in Fig 2, the pairs 
TULV/ PUUV, SNV/ANDV, and HTNV/SEOV represented three major groups of 
hantaviruses associated, respectively, with Cricetid/Arvicoline, 
Cricetid/Neotomine-Sigmodontine, and  Murid/Murine rodents. Gn-CT protein is highly 
conserved among different hantaviruses with >40% sequence conservation, and most of 
the aa residues important for maintaining the 3D structure such as cysteines, bulk 
aromatic, hydrophobic and charged residues, as well as glycines and prolines are identical 
in all hantavirus sequences. The two zinc finger motifs are conserved in all hantaviruses 
while the ITAM is conserved in Tula and Sin Nombre- and Andes-like viruses. Such a 
conservation suggests a similar mode of folding, and hence similar or even identical 
function, of the Gn-CT in different hantavirus species.  
 
8.2 Degradation and aggresome formation of Gn-CT may be a general property 
of most hantaviruses 
As described in the results section, we observed degradation of TULV and PHV 
Gn-CT both in human HEK-293 and simian Vero E6 cells and the hantavirus Gn-CT 
had a tendency to self-associate into large protein aggregates. It was reported that 
when SNV Gn full-length protein expressed in the absence of Gc it has the tendency 
to form SDS-stable oligomers (Spiropoulou et al., 2003). Such multimers could also 
be seen in immunoprecipitation experiments of the HTNV Gn (Antic et al., 1992; 
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Hooper et al., 2001; Pensiero and Hay, 1992), and the SNV Gn protein was found in 
aggresomes when overexpressed (Spiropoulou et al., 2003). Taken together the results 
and other reports, however, suggest that the degradation and aggregation of the 
envelope protein Gn may be a general property of most hantaviruses and is unrelated 
to pathogenicity.  
 
8.3 The role of ITAM and zinc finger motifs in the interaction of N and Gn-CT 
We found that the ITAM motifs carried by Gn-CT can be removed without 
affecting the capability of the tail to interact with N (II). In contrast, zinc fingers 
appeared to be crucial for the interaction. The mutations of either of the two zinc 
fingers totally abolished the Gn-CT/N interaction. These results supported the idea 
that, unlike other type zinc fingers forming a "beads-on-a-string" configuration, the 
hantavirus Gn-CT zinc fingers fold into unique, compact stucture (Estrada et al., 
2009). The data on the modeling of Gn-CT (II, Fig. 6) also supported this notion: two 
quartets of Zn-coordinating aa residues are located in close proximity. The tight fold 
of the whole zinc finger domain could explain the results of experiments with EDTA 
treatment (II, Fig. 4) in which the interacting capability of the Gn-CT was not totally 
abolished; it seemed that a portion of Zn
2+
 cations remained in contact with cysteine 
and histidine residues thus helping to maintain correct folding of at least some Gn-CT 
molecules.  
 
8.4 The role of hantavirus RNA in the induction of innate immunity 
As shown in results section, we found that Old World hantaviruses do not 
produce detectable amounts of dsRNA in infected cells and the 5’-termini of their 
genomic RNAs are monophosphorylated. These results suggest that the hantavirus 
RNA may be only minimally involved in the induction of innate immunity. In 
accordance with this presumption, UV-inactivated Sin Nombre virus can activate the 
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innate immunity response at early time points post infection in HUVEC cells 
considering that the UV irradiation could dramatically destroy the integrity of RNA 
(Prescott et al., 2010; Prescott et al., 2005). However, there are also several 
contradictory reports: UV-inactivated PHV, ANDV and HTNV viruses were reported 
to be unable to induce the innate immunity; and the TLR3 was needed for HTNV to 
trigger IFN innate immunity induction (Handke et al., 2009; Spiropoulou et al., 2007). 
In addition, we can not exclude the possibility that the amounts of dsRNA produced 
by hantaviruses are below our detection limit since one molecule of dsRNA per cell 
can activate IFN production (Marcus and Sekellick, 1977). Therefore, whether 
hantavirus RNAs are actually involved in the innate immunity induction needs further 
characterization. 
 
8.5 The role of Gn-CT of TULV in inhibition of innate immunity  
Hantavirus Gn are reported to be involved in the inhibition of both 
IFN-induction and signaling. Gn-CT of NY-1V was found to coprecipitate the 
N-terminal domain of TRAF3 and disrupt the formation of TRAF3-TBK1 complex, 
thus regulating the RIG-I and TBK-1 directed immune response (Alff et al., 2006; 
Alff et al., 2008). The Gn of both ANDV and PHV were shown to inhibit nuclear 
translocation of STAT-1 (Spiropoulou et al., 2007). Most recently, it was reported that 
IFN-β induction is inhibited of coexpression of ANDV N protein and GPC and is 
robustly inhibited by SNV GPC alone. Downstream amplification by Jak/STAT 
signaling is also inhibited by SNV GPC and by either NP or GPC of ANDV (Levine 
et al., 2010). In addition, it has been reported that the TLR3 and TLR4 are involved in 
the HTNV-induced innate immunity, but the mechanism remains unknown (Handke et 
al., 2009; Jiang et al., 2008). TLRs mediate the signal transduction through two 
possible ways, Myd88 and TRIF. TLR4 operates both through the MyD88 and TRIF 
pathways, TLR3 signals through TRIF and all the other TLRs mediate through the 
MyD88 pathway (Amati et al., 2006; Foster et al., 2007; O'Neill, 2006; Pandey and 
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Agrawal, 2006) (Fig. 3). TRIF and RLH pathways converge on the formation of 
TBK1/IKKϵ complex thus catalyzing the phosphorylation of IRF-3 and IRF-7. 
MyD88 activates IFN through another pathway: it interacts directly with IRF-7 to 
activate the signaling pathway (Fig 3). Cotransfection of expression plasmids for 
MyD88 and IRF-7 together with the IFN- promoter-driven reporter gene would 
strongly induced the reporter gene. In our study these two major pathways, 
TBK1/IKK and MyD88/IRF-7, were assessed. We found that TULV Gn-CT can 




9 Concluding remarks  
Recently the hantavirus Gn protein has been studied extansively by several groups, 
but still many questions remain unknown. Our study on Gn protein included different 
aspects, synthesis and degradation (I), interaction with N protein (II), and role in innate 
immunity (IV). Also we carried out a project to study how the hantavirus induces innate 
immunity (III). 
In this thesis, we first found the Gn-CT of the apathogenic hantaviruses (TULV, 
PHV) are degraded through the ubiquitin-proteasome pathway both in human 
HEK-293 and simian Vero E6 cells and TULV Gn-CT formed aggresome upon 
treatment of proteasomal inhibitors. Second, we found that the TULV Gn-CT fused 
with GST tag expressed in bacteria could pull-down the N protein expressed in 
mammalian cells and that the zinc finger motifs in Gn-CT and RNA binding motif in N 
protein are indispensable for the interaction. Third, we found that Old World 
hantaviruses do not produce detectable amounts of dsRNA in infected cells and the 
5’-termini of their genomic RNAs are monophosphorylated. The hantavirus RNA may 
be only minimally involved in the induction of innate immunity. Finally, we found 
that the Gn-CT of TULV inhibits the IFN transcriptional activation through TLR and 
RLH pathway and that the inhibition target lies at the level of TBK-1/IKK complex 




10 Future prospects 
As the mechanism hantaviruses use to activate innate immunity remains unknown, in 
the future studies, this should be investigated in more detail. It has been reported recently 
that short double-stranded RNA/DNA without tri-ppp can activate the RIG-I response, 
thus whether the panhandle structure of hantavirus genomic RNA may activate the innate 
immunity is an open question and needs to be studied later. In addition, the viral transcript 
(mRNA) has been reported to be able to activate innate immunity after RNase L digestion 
(Luthra et al., 2011). Does the hantavirus mRNA also have a similar effect? This also 
should be investigated in more detail. Furthermore, currently there are no unified 
conclusions on the inhibitory effect of different hantavirus glycoproteins. Is the inhibitory 
effect related to the pathogenesis? How is the difference generated? Studies comparing all 
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